Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong-Liang Qiu

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
International Journal of Biological Sciences|April 20, 2026
Deciphering Uncoupling Proteins in Cellular Homeostasis and Metabolic HealthYu-Ting Liu, Ya-Jia Ding, Hong-Liang Qiu, et al.
Journal of Advanced Research|August 20, 2025
Nuciferine inhibits pressure overload-induced cardiac remodeling by activating the SENP1-ACSL4-ferroptosis axisYu-Ting Liu, Ya-Jia Ding, Yan Che, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 18, 2024
Tectorigenin protects against cardiac fibrosis in diabetic mice heart via activating the adiponectin receptor 1-mediated AMPK pathwayYu-Lan Ma, Man Xu, Xian-Feng Cen, et al.
Ageing Research Reviews|December 23, 2023
ADP-ribosylation: An emerging direction for disease treatmentYu-Ting Liu, Yan Che, Hong-Liang Qiu, et al.
Frontiers in Cardiovascular Medicine|April 18, 2022
Screening of Lipid Metabolism-Related Gene Diagnostic Signature for Patients With Dilated CardiomyopathyMan Xu, Ying-Ying Guo, Dan Li, et al.
Frontiers in Cardiovascular Medicine|July 5, 2023
Identify Tcea3 as a novel anti-cardiomyocyte hypertrophy gene involved in fatty acid oxidation and oxidative stressYingying Guo, Xian-Feng Cen, Dan Li, et al.
Acta Pharmacologica Sinica|December 17, 2021
Lupeol protects against cardiac hypertrophy via TLR4-PI3K-Akt-NF-κB pathwaysDan Li, Ying-Ying Guo, Xian-Feng Cen, et al.
British Journal of Pharmacology|June 21, 2022
Limonin stabilises sirtuin 6 (SIRT6) by activating ubiquitin specific peptidase 10 (USP10) in cardiac hypertrophyLi-Bo Liu, Si-Hui Huang, Hong-Liang Qiu, et al.
Oxidative Medicine and Cellular Longevity|March 4, 2022
Diosmetin Protects against Cardiac Hypertrophy via p62/Keap1/Nrf2 Signaling PathwayYingying Guo, Dan Li, Xian-Feng Cen, et al.
Acta Pharmacologica Sinica|March 8, 2024
Macrod1 suppresses diabetic cardiomyopathy via regulating PARP1-NAD<sup>+</sup>-SIRT3 pathwayYu-Ting Liu, Hong-Liang Qiu, Hong-Xia Xia, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
International Journal of Biological Sciences|April 20, 2026
Deciphering Uncoupling Proteins in Cellular Homeostasis and Metabolic HealthYu-Ting Liu, Ya-Jia Ding, Hong-Liang Qiu, et al.
Journal of Advanced Research|August 20, 2025
Nuciferine inhibits pressure overload-induced cardiac remodeling by activating the SENP1-ACSL4-ferroptosis axisYu-Ting Liu, Ya-Jia Ding, Yan Che, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 18, 2024
Tectorigenin protects against cardiac fibrosis in diabetic mice heart via activating the adiponectin receptor 1-mediated AMPK pathwayYu-Lan Ma, Man Xu, Xian-Feng Cen, et al.
Ageing Research Reviews|December 23, 2023
ADP-ribosylation: An emerging direction for disease treatmentYu-Ting Liu, Yan Che, Hong-Liang Qiu, et al.
Frontiers in Cardiovascular Medicine|April 18, 2022
Screening of Lipid Metabolism-Related Gene Diagnostic Signature for Patients With Dilated CardiomyopathyMan Xu, Ying-Ying Guo, Dan Li, et al.
Frontiers in Cardiovascular Medicine|July 5, 2023
Identify Tcea3 as a novel anti-cardiomyocyte hypertrophy gene involved in fatty acid oxidation and oxidative stressYingying Guo, Xian-Feng Cen, Dan Li, et al.
Acta Pharmacologica Sinica|December 17, 2021
Lupeol protects against cardiac hypertrophy via TLR4-PI3K-Akt-NF-κB pathwaysDan Li, Ying-Ying Guo, Xian-Feng Cen, et al.
British Journal of Pharmacology|June 21, 2022
Limonin stabilises sirtuin 6 (SIRT6) by activating ubiquitin specific peptidase 10 (USP10) in cardiac hypertrophyLi-Bo Liu, Si-Hui Huang, Hong-Liang Qiu, et al.
Oxidative Medicine and Cellular Longevity|March 4, 2022
Diosmetin Protects against Cardiac Hypertrophy via p62/Keap1/Nrf2 Signaling PathwayYingying Guo, Dan Li, Xian-Feng Cen, et al.
Acta Pharmacologica Sinica|March 8, 2024
Macrod1 suppresses diabetic cardiomyopathy via regulating PARP1-NAD<sup>+</sup>-SIRT3 pathwayYu-Ting Liu, Hong-Liang Qiu, Hong-Xia Xia, et al.
Pageof 2